5% Off
Fatisol10%
Popular Pharmaceuticals Ltd.
৳570.00
Add to cart
Generic medicine
Intravenous Fat Emulsion: Brands, Price & Uses in Bangladesh
Intravenous Fat Emulsion is a lipid-based component of parenteral nutrition.
About Intravenous Fat Emulsion
Indications of Intravenous Fat Emulsion
Intravenous Fat Emulsion is a lipid-based component of parenteral nutrition. Its use can be classified by strength of evidence as follows:
Established / FDA-approved uses
- Source of calories and essential fatty acids as part of total or partial parenteral nutrition (PN) for patients who cannot meet their nutritional requirements through oral or enteral feeding, typically for extended periods (usually more than 5 days). This includes patients with major gastrointestinal disorders (e.g., short bowel syndrome, severe malabsorption, bowel obstruction, high-output fistulas), prolonged unconsciousness or inability to swallow, extensive burns, severe cachexia, and pre- or post-operative patients unable to tolerate adequate enteral intake.
- Prevention and treatment of essential fatty acid deficiency (EFAD) when the diet cannot provide sufficient linoleic and other essential fatty acids.
Guideline-supported / adjunct uses
- As a calorically dense, non-carbohydrate energy source within a complete parenteral nutrition regimen to reduce glucose load and associated hyperglycemia in critically ill or metabolically stressed patients, always used in combination with amino acids, dextrose, electrolytes, vitamins, and trace elements as part of the overall nutrition plan, not as a stand-alone therapy.
- Nutritional support in patients with renal impairment on restricted protein/fluid intake, as part of an individualized parenteral nutrition regimen supervised by a physician.
Intravenous Fat Emulsion is never given as a sole or isolated therapy; it is always prescribed and administered as part of a complete, physician-supervised parenteral nutrition program with appropriate laboratory monitoring.
Dosage & Administration of Intravenous Fat Emulsion
Intravenous Fat Emulsion must be administered only under close medical supervision as part of a complete, individualized parenteral nutrition regimen, with regular monitoring of the patient's ability to metabolize and clear infused lipid.
Adult Dosage
| Parameter | Recommendation |
|---|---|
| Initial dose | Approximately 1 g/kg/day (lower in critically ill patients) |
| Maximum dose | Generally not to exceed 2.5 g/kg/day |
| Initial infusion rate | Approximately 0.5-1 mL/minute (10%) for the first 15-30 minutes, observing closely for adverse reactions |
| Maintenance infusion rate | Increased gradually as tolerated, generally not exceeding 0.5 mL/kg/hour, so that lipid does not exceed the patient's clearance capacity |
Pediatric Dosage
| Age Group | Recommendation |
|---|---|
| Infants and children (including neonates) | Initial dose approximately 0.5-1 g/kg/day, increased gradually in increments; maximum generally 3 g/kg/day |
| Neonates and preterm infants | Very slow, closely monitored initial infusion rates; strict adherence to maximum hourly infusion rate limits is essential given reports of acute respiratory distress with rapid infusion in this population |
Renal/Hepatic Adjustment
No universal fixed dose reduction is established; however, patients with hepatic impairment require closer monitoring of liver function and lipid clearance, and dose/rate should be individualized conservatively. Patients with renal impairment may require adjustment of overall parenteral nutrition composition by the treating physician.
See Administration for infusion technique and Precautions and Warnings for monitoring requirements.
Side Effects of Intravenous Fat Emulsion
Side effects of Intravenous Fat Emulsion are generally related to infusion rate and duration of therapy.
Common
- Fever, chills, or shivering during or shortly after infusion
- Nausea and vomiting
- Flushing, sweating
Less common / serious
- Hypersensitivity reactions (rash, urticaria, dyspnea, and rarely anaphylaxis)
- Elevated liver enzymes and cholestasis with prolonged use
- Thrombocytopenia or, rarely, hemolysis
- Thrombophlebitis at the infusion site (with peripheral administration)
- Fat overload syndrome (see Precautions and Warnings)
Contraindications of Intravenous Fat Emulsion
Intravenous Fat Emulsion is contraindicated in the following situations (true absolute contraindications only):
- Known hypersensitivity to egg protein, soybean protein, peanut protein, or any other component of the specific product formulation.
- Severe disorders of lipid metabolism characterized by pathologic hypertriglyceridemia (e.g., serum triglycerides persistently above approximately 1,000 mg/dL) or other severe hyperlipidemias.
- Acute pancreatitis accompanied by hyperlipidemia.
Conditions requiring caution rather than absolute avoidance (e.g., hepatic impairment, risk factors for fat overload syndrome, preterm/low-birth-weight infants) are discussed under Precautions and Warnings.
Frequently Asked Questions about Intravenous Fat Emulsion
What is Intravenous Fat Emulsion used for?
Intravenous Fat Emulsion is used to provide calories and essential fatty acids to patients who cannot get enough nutrition through eating or tube feeding, as part of a complete parenteral (intravenous) nutrition program, and to prevent or treat essential fatty acid deficiency.
How is Intravenous Fat Emulsion given?
Intravenous Fat Emulsion is given only as a slow intravenous infusion in a hospital or supervised clinical setting, usually alongside other nutrition solutions (amino acids, dextrose, vitamins, and electrolytes), starting at a low rate that is gradually increased while the patient is monitored closely.
Who should not receive Intravenous Fat Emulsion?
Intravenous Fat Emulsion should not be given to patients with known allergy to egg, soybean, or peanut protein, patients with severe disorders of fat metabolism with very high triglyceride levels, or patients with acute pancreatitis associated with hyperlipidemia.
What are the main side effects of Intravenous Fat Emulsion?
Common side effects include fever, chills, nausea, and vomiting during infusion. More serious but less common effects include allergic reactions, liver function changes with prolonged use, and a rare complication called fat overload syndrome, which can cause sudden fever, anemia, and liver problems if the body cannot clear the infused fat properly.
Is Intravenous Fat Emulsion safe during pregnancy or breastfeeding?
Intravenous Fat Emulsion should be used during pregnancy only if clearly needed and under close physician supervision, since it should be used only when the benefit justifies any potential risk. It is generally considered acceptable during breastfeeding when medically indicated, but a physician should always be consulted first.
What happens if too much Intravenous Fat Emulsion is given?
Giving too much or infusing Intravenous Fat Emulsion too quickly can cause fat overload syndrome or, in newborns, serious breathing problems. If this is suspected, the infusion is stopped immediately and the patient is given prompt medical evaluation and supportive care; this is why Intravenous Fat Emulsion is always administered under close medical supervision.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.